Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110224 · ClinicalTrials.gov registry record
SCP® Observational Study of the Knee
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 516
- Enrollment target
NCT03110224: Clinical Trial study, sponsored by Zimmer Biomet.
NCT03110224 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 516 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03110224 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 516 participants
- Enrollment target
Study Summary
Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty (SCP) Procedure in the knee in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, function, activity levels and patient satisfaction.
Primary Outcome
Change from baseline score of pain intensity at 12 months. To collect VAS, patients marked a slash on a 10 cm horizontal line, with 0 cm indicating "no pain" and 10 cm indicating "worst possible pain." The distance from the left end of the line to the patient's mark was measured by the administrator in centimeters. Lower numbers were representative of lower pain levels.
Interventions
- DEVICE Subchondroplasty Procedure with AccuFill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2012-09-18 |
| Est. Completion | 2023-05-31 |
Why NCT03110224 stopped before completion
NCT03110224 is an observational study that tracks outcomes without assigning an intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Subchondroplasty Procedure with AccuFill is the first listed.
NCT03110224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03110224 about?
NCT03110224 is a clinical study titled "SCP® Observational Study of the Knee". Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty (SCP) Procedure in the knee in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, function, acti...
What is the current status of trial NCT03110224?
This trial is currently terminated. The enrollment target is 516 participants. The study started on 2012-09-18. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03110224?
The interventions under investigation include: Subchondroplasty Procedure with AccuFill (DEVICE).
Who is sponsoring clinical trial NCT03110224?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI